US 7,067,636 B2 · Anti-pro 1017 antibodies

Abstract

The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

Claims5

Dependent claims

An isolated antibody that specifically binds to the polypeptide of amino acid sequence set for thin SEQ ID NO:466.

Dependencies are inferred from the claim text.

Facts

Application

10/145,016Filed 18 Oct 2001 · continuation

Priority

22 May 1998

Published

US 2003/0060406 A130 Oct 2003

Granted

27 Jun 2006

Term ends

Not estimatedThe source records don’t support an estimate.

Classification10 codes

C07K 16/18
Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies: against material from animals or humans
C07K 14/47
From vertebrates: from mammals
C07K 14/4703
Regulators; Modulating activity: inhibitors; Suppressors
C07K 14/705
From animals; from humans: receptors; Cell surface antigens; Cell surface determinants

Family

Application60/086,414Us provisional application · filed 22 May 1998

Application60/113,296Us provisional application · filed 22 Dec 1998

PCT/US99/00106Parent of this continuation-in-part · filed 5 Jan 1999

PCT/US99/05028Parent of this continuation-in-part · filed 8 Mar 1999

PCT/US00/04341Parent of this continuation · filed 18 Feb 2000

Application09/918,585Parent of this continuation · filed 30 Jul 2001

US 2003/0203433 A1Pre-grant publication · published 30 Oct 2003

Application09/380,138Parent of this continuation-in-part

PCT/US00/04341Parent of this continuation-in-part

Application09/284,291Parent of this continuation-in-part

US 2003/0060406 A1Published application

US 7,067,636 B2This patent

From the US filing history. Foreign family members aren’t listed.

Abstract

Facts

Application

10/145,016Filed 18 Oct 2001 · continuation

Priority

22 May 1998

Published

US 2003/0060406 A130 Oct 2003

Granted

27 Jun 2006

Term ends

Not estimatedThe source records don’t support an estimate.

Classification10 codes

C07K 16/18
Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies: against material from animals or humans
C07K 14/47
From vertebrates: from mammals
C07K 14/4703
Regulators; Modulating activity: inhibitors; Suppressors
C07K 14/705
From animals; from humans: receptors; Cell surface antigens; Cell surface determinants

Family

Application60/086,414Us provisional application · filed 22 May 1998

Application60/113,296Us provisional application · filed 22 Dec 1998

PCT/US99/00106Parent of this continuation-in-part · filed 5 Jan 1999

PCT/US99/05028Parent of this continuation-in-part · filed 8 Mar 1999

PCT/US00/04341Parent of this continuation · filed 18 Feb 2000

Application09/918,585Parent of this continuation · filed 30 Jul 2001

US 2003/0203433 A1Pre-grant publication · published 30 Oct 2003

Application09/380,138Parent of this continuation-in-part

PCT/US00/04341Parent of this continuation-in-part

Application09/284,291Parent of this continuation-in-part

US 2003/0060406 A1Published application

US 7,067,636 B2This patent

From the US filing history. Foreign family members aren’t listed.

Anti-pro 1017 antibodies

Life of this patent

Abstract

Claims5

Anti-pro 1017 antibodies

Life of this patent

Abstract

Claims5